Provided by Tiger Trade Technology Pte. Ltd.

Xtant Medical

0.2100
-0.0061-2.82%
Post-market: 0.2010-0.0090-4.29%17:05 EST
Volume:257.13K
Turnover:59.18K
Market Cap:29.40M
PE:-1.84
High:0.2500
Open:0.2500
Low:0.2000
Close:0.2161
52wk High:0.8400
52wk Low:0.1700
Shares:140.00M
Float Shares:54.29M
Volume Ratio:0.55
T/O Rate:0.47%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1142
EPS(LYR):0.0300
ROE:-36.53%
ROA:-7.62%
PB:0.79
PE(LYR):7.00

Loading ...

Xtant Medical price target lowered to 50c from 60c at Craig-Hallum

TIPRANKS
·
Nov 17

Xtant Medical’s Risky Bet on HEMOBLAST Bellows: Rising Costs, Supply Dependence on Dilon, and a $5 Million Write-Off

TIPRANKS
·
Nov 17

Xtant Medical Holdings Inc : Maxim Group Cuts to Hold from Buy

THOMSON REUTERS
·
Nov 17

Vivos Therapeutics Q3 Revenue Rises on Service Segment Growth

Reuters
·
Nov 17

Xtant Medical downgraded to Hold from Buy at Maxim

TIPRANKS
·
Nov 17

INVO Fertility Q3 Revenue Rises 26% on Clinic Growth, Net Loss Narrows

Reuters
·
Nov 16

Xtant Medical Q3 Revenue Misses Estimates; Withdraws Guidance

Reuters
·
Nov 16

Xtant Medical Hldgs Q3 EPS $(0.03) Misses $(0.02) Estimate, Sales $24.285M Miss $25.512M Estimate

Benzinga Earnings
·
Nov 16

Xtant Medical Q3 Revenue USD 24.3 Million

Reuters
·
Nov 16

Xtant Medical - no Longer Expects to Achieve Previously Issued Full-Year 2026 Guidance

THOMSON REUTERS
·
Nov 16

Xtant Medical Holdings Inc: not Providing Revised Full-Year 2026 Financial Guidance

THOMSON REUTERS
·
Nov 16

Xtant Medical Q3 EPS USD -0.03

THOMSON REUTERS
·
Nov 16

Xtant Medical Reports Third Quarter 2026 Financial Results and Announces Board-Led Strategic Review Process

THOMSON REUTERS
·
Nov 16

Xtant Medical to Report Third-Quarter Financial Results

Reuters
·
Nov 10

Adagio Medical Treats 22 Patients with vCLAS Ultra Ablation System

Reuters
·
Nov 10

Adagio Medical Holds Special Stockholder Meeting

Reuters
·
Oct 26

Retrieve Medical Strikes National Distribution Deal for Retrieve Passport with US Financial Services Platform

Reuters
·
Oct 08

Adagio Medical Issues 4,978,869 Shares in $776,111 Convertible Note Conversion

Reuters
·
Oct 02

Adagio Medical Treats First Patient in IDE Study of Next-Generation vCLAS Ultra System for Ventricular Tachycardia

Reuters
·
Sep 16

Xtant Medical Holdings Price Target Announced at $1.00/Share by LUCID Capital Markets

Dow Jones
·
Sep 02